Viracta Therapeutics Overview
Viracta Therapeutics Discounted Cash Flow
DCF Analysis for VIRX.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.34
Current Fair Value
$-0.34
↓ 3598.0% Downside
Overvalued by 3598.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison